Centerra Gold (CGAU)
(Delayed Data from NYSE)
$7.13 USD
-0.10 (-1.38%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $7.13 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Price, Consensus and EPS Surprise
CGAU 7.13 -0.10(-1.38%)
Will CGAU be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CGAU based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CGAU
What Makes Centerra Gold (CGAU) a New Buy Stock
Are Investors Undervaluing Centerra Gold (CGAU) Right Now?
CGAU: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Cabot (CBT) Outperforming Other Basic Materials Stocks This Year?
Is Centerra Gold (CGAU) Stock Undervalued Right Now?
Is Centerra Gold (CGAU) Stock Outpacing Its Basic Materials Peers This Year?
Other News for CGAU
Centerra Gold Announces Upcoming Q3 2024 Results
Centerra Gold price target lowered by C$0.50 at Raymond James
Kestrel provides update on work completed by Centerra on QCM
Centerra Gold price target raised by C$1 at BMO Capital
Centerra Gold Buy Rating Affirmed Amidst Strong Molybdenum Operations Outlook and Solid Financial Health